MedPath

Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT)

Not yet recruiting
Conditions
Depressive Disorder
Malingering
Interventions
Diagnostic Test: Niacin skin reaction test
Registration Number
NCT06382532
Lead Sponsor
Air Force Military Medical University, China
Brief Summary

This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger. The investigators expect that depressive disorder malinger can be discriminated by the niacin skin reaction test.

Detailed Description

Depressive disorder malingers are prevalent, and it is difficult to recognize. As an objective and scientific endophenotype of depressive disorders, the blunted features in NSRT are determined by genetic factors and are not influenced by the mental state of individual subjects at a particular moment, which can provide a reliable retrospective biological index for the determination of mental and psychological state of depressive disorder malinger.

This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger, explore the application prospects of this technology in the field of biological identification, and establish a high-specificity biological diagnostic model for depressive disorder malinger and validate and optimize it, so as to provide a biological basis for the accurate and efficient identification of depressive disorder malingers using objective indexes in the process of clinical practice.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
410
Inclusion Criteria

Depressive Disorder Malinger Group:

  1. Clinical complaints meeting DSM-5 criteria for the diagnosis of depressive disorder;
  2. Patients with first-episode fraudulent disease who meet the DSM-5 criteria for the diagnosis of Z76.5;
  3. Age 18-60 years, Males;
  4. Voluntary informed consent.

Depressive Disorder Group:

  1. Patients with a first depressive disorder meeting DSM-5 criteria;
  2. Age 18-60 years, Males;
  3. Voluntary informed consent.

Healthy control group:

  1. M.I.N.I scale rating without any mental disorder;
  2. PHQ-9 <5 ;
  3. No history of mental illness, no family genetic history;
  4. Age 18-60 years old, Males;
  5. Voluntary informed consent form.
Exclusion Criteria
  1. History of traumatic brain injury;
  2. Continuous use of non-steroidal anti-inflammatory drugs within the last two weeks.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Depressive disorder groupNiacin skin reaction test1. Patients with a first depressive disorder meeting DSM-5 criteria; 2. Age 18-60 years, Males; 3. Voluntary informed consent.
Depressive disorder malinger groupNiacin skin reaction test1. Clinical complaints meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for the diagnosis of depressive disorder; 2. Patients with first-episode fraudulent disease who meet the DSM-5 criteria for the diagnosis of Z76.5; 3. Age 18-60 years, Males; 4. Voluntary informed consent.
Healthy control groupNiacin skin reaction test1. M.I.N.I scale rating without any mental disorder; 2. Patient Health Questionnaire (PHQ-9) \< 5; 3. No history of mental illness, no family genetic history; 4. Age 18-60 years old, Males; 5. Voluntary informed consent form.
Primary Outcome Measures
NameTimeMethod
Niacin reaction testDuring the intervention

Total niacin reaction score: It includes one value (Total Area), which refers to the sum of nicotinic acid reaction areas for each concentration (a total of 360) collected within 10 minutes from 60 images.

Total single point score for niacin reaction: It includes six values, each representing the sum of nicotinic acid reaction areas for individual concentrations (a total of 360) collected within 10 minutes from 60 images.

Niacin reaction speed: It includes one value (EC50), representing the time required for the nicotinic acid reaction of the first concentration to reach half of the plateau phase.

Niacin flush color: It includes one value (Total Color), which refers to the color value of 6 flush areas in the images captured at the 10th minute.

Secondary Outcome Measures
NameTimeMethod
The F Scale in Minnesota Multiphasic Personality InventoryBaseline, pre-intervention

The F Scale in Minnesota Multiphasic Personality Inventory (MMPI) is used to detect attempts at fraud.

Model specificity and sensitivityThrough study completion, an average of 2 years

Evaluate the effectiveness of the classification model in identifying feigned depression patients through measures such as the area under curve (AUC), sensitivity (Sen), specificity (Sep), positive predictive value (PPV), and negative predictive value (NPV), where higher AUC, Sen, Sep, PPV, and NPV values indicate better classification performance of the model.

Trial Locations

Locations (1)

Air Force Medical Center

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath